Inventor · disambiguated record
Olof Andries Blokzijl
Also filed as: BLOKZIJL OLOF ANDRIES
2 granted patents·2 pending applications·1 citations·filing 2016–2018
30Inventor score
Files withGENAGON THERAPEUTICS AB4
Top patents by PatentIndex Score
4 records- 0165US11628224B2Therapeutic agents targeting CLPTM1GENAGON THERAPEUTICS AB·Filed 2018·Granted Apr 18, 2023·1 cites·24 claims
- 0238US11406665B2Therapeutic peptides that target TGF-beta interactionGENAGON THERAPEUTICS AB·Filed 2018·Granted Aug 9, 2022·0 cites·10 claims
- 0327US2019256592A1Binding agents for use in therapyGENAGON THERAPEUTICS AB·Filed 2017·Application pending·0 cites
- 0425US2018282403A1Agents for reducing the activity of gdf15GENAGON THERAPEUTICS AB·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Olof Andries Blokzijl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →